download

Brochure for RYBREVANT® + LAZCLUZE

A general guide to the first treatment of NSCLC with exon 19 deletions or exon 21 L858R substitution mutations.

RYVBREVANT® (amivantamab-vmjw) Patient Brochure

Brochure for RYBREVANT® + chemotherapy

A general guide to the second treatment of NSCLC with EGFR exon 19 deletions or exon 21 L858R mutations and the first treatment of NSCLC with EGFR exon 20 insertion mutations.
RYVBREVANT® (amivantamab-vmjw) Doctor Discussion Guide

Doctor Discussion Guide

Tips and example questions for having a helpful discussion with your doctor.
Wallet card with treatment information brochure thumbnail

Wallet Card

A small card with your treatment information on it so that you can keep it with you and show it to any new members of your care team.

1st treatment of NSCLC with common EGFR mutations brochure thumbnail

Treatment Journal

A notebook designed to help support you during treatment and at your doctor appointments, including resources to help you stay organized and to talk to your care team.

Man in orange shirt talking with a man in a white roomFather enjoying quality time with his son

Facing cancer together

Facing lung cancer comes with many challenges, but you're not alone. There are many groups made to help people facing lung cancer and their loved ones.

Learn about the groups

Share your story

If you or a loved one were treated with RYBREVANT®, we want to hear about your experience.

Mom enjoying quality time with daughterMom enjoying quality time with daughter

Savings & Support

Once prescribed a RYBREVANT®-based treatment, connect with a Care Navigator for your support needs.

Rybrevant withMe logo with patientRybrevant withMe logo with patient
The support and resources provided by RYBREVANT withMe are not intended to provide medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment.

EGFR = epidermal growth factor receptor, NSCLC = non–small cell lung cancer